Experimental Drug Eliminates 75% of Aggressive Pancreatic Tumors and Enhances Immune System Memory
4 Articles
4 Articles
Experimental drug eliminates 75% of aggressive pancreatic tumors and enhances immune system memory
Many solid tumors, including many cancers of the pancreas, breast, colon and lung, protect themselves with a dense wall of scar-like tissue. That wall keeps the immune system's cancer-killing T cells out. It is a major reason why immunotherapy drugs, which have transformed treatment for some patients, help only a minority of people with solid tumors.
Experimental immunotherapy breaks down the barrier of solid tumours in mice and leaves cancer memory to the immune system. The article Immunotherapy: in mice a drug teaches to remember cancer is taken from the Future Next.
New drug eliminated pancreatic and breast tumors in mice and created lasting immunity from cancer by breaking the protective barrier of the tumors.
Preclinical Findings Show Experimental Drug Eliminates 75% of Aggressive Pancreatic Tumors and Enhances Immune System Memory to Fight Other Cancers
A study published in Cancer Cell describes how in mice the drug cleared aggressive pancreatic tumors, stopped breast cancer from spreading, and left the animals with long-lasting immune memory. That memory protected against new tumors, including some different types of cancer.
Coverage Details
Bias Distribution
- 100% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
